Cargando…
Transthyretin Cardiac Amyloidosis: Pathogenesis, Treatments, and Emerging Role in Heart Failure with Preserved Ejection Fraction
Transthyretin (TTR) amyloidosis causes heart failure from cardiac deposition of TTR amyloid fibrils, the by-product of TTR homotetramer disassembly. Wild-type (WT) TTR deposition leads to senile amyloidosis, predominantly manifesting with cardiomyopathy. Missense mutations in the TTR gene result in...
Autores principales: | Ton, Van-Khue, Mukherjee, Monica, Judge, Daniel P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284988/ https://www.ncbi.nlm.nih.gov/pubmed/25628512 http://dx.doi.org/10.4137/CMC.S15719 |
Ejemplares similares
-
Cardiac Transthyretin-derived Amyloidosis: An Emerging Target in Heart Failure with Preserved Ejection Fraction?
por: Klaassen, Sebastiaan HC, et al.
Publicado: (2020) -
Prevalence of transthyretin amyloidosis among heart failure patients with preserved ejection fraction in Japan
por: Naito, Takanori, et al.
Publicado: (2023) -
Wild type transthyretin amyloidosis, a reason not to be forgotten for heart failure of preserved ejection fraction in the elderly
por: TIAN, Zhuang, et al.
Publicado: (2020) -
Transthyretin cardiac amyloidosis: an under-diagnosed cause of heart failure
por: Molina O, Gabriela, et al.
Publicado: (2014) -
Cardiac Amyloidosis and its New Clinical Phenotype: Heart Failure
with Preserved Ejection Fraction
por: Mesquita, Evandro Tinoco, et al.
Publicado: (2017)